Jan 4, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2022-D-2061-0008
Association for Accessible Medicines (AAM) comment letter
FDANonrulemakingFDA-2022-D-2061
Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA; Draft Guidance for Industry; Availability
RIN
—
Last modified
Dec 3, 2025
Comment window
closed 1301d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Jan 4, 2023 and Jan 4, 2023. 0 other organizations filed here. The comment window closed 1301d ago.
What Association for Accessible Medicines filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%